Aigen Investment Management’s Veracyte VCYT Stock Holding History

Aigen Investment Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,412	Closed	-$354K	–	1014
2024 Q3	$354K	Buy	+10,412	New	+$293K	0.07%	414
2024 Q1	–	Sell	-7,994	Closed	-$220K	–	1032
2023 Q4	$220K	Buy	+7,994	New	+$193K	0.04%	630
2021 Q2	–	Sell	-8,662	Closed	-$466K	–	747
2021 Q1	$466K	Sell	8,662 -7,593	-47%	-$437K	0.06%	301
2020 Q4	$796K	Buy	+16,255	New	+$753K	0.1%	260
2020 Q3	–	Sell	-8,316	Closed	-$215K	–	1118
2020 Q2	$215K	Buy	8,316 +5,045	+154%	+$126K	0.03%	694
2020 Q1	$80K	Sell	3,271 -2,958	-47%	-$74.5K	0.01%	909
2019 Q4	$174K	Buy	+6,229	New	+$161K	0.03%	588

Other funds holding VCYT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Aigen Investment Management's VCYT Position: Q4 2024 in Review

Aigen Investment Management sold out of Veracyte (VCYT) in Q4 2024, closing a stake of 10,412 shares — an estimated $354K sold.

Aigen Investment Management first reported a position in VCYT in Q4 2019 and held it in 7 quarters. The position peaked at $796K in Q4 2020. 318 funds tracked by Wall St. Rank hold VCYT as of Q4 2024.

Aigen Investment Management reported no remaining Veracyte position as of Q4 2024 after selling out during the quarter.
Aigen Investment Management sold 10,412 Veracyte shares in Q4 2024, an estimated $354K.
Aigen Investment Management first reported a position in Veracyte in Q4 2019 and held it in 7 quarters.
Aigen Investment Management's Veracyte position peaked at $796K in Q4 2020.
318 funds tracked by Wall St. Rank held Veracyte as of Q4 2024.

Based on Aigen Investment Management's 13F filing for Q4 2024, filed 6 Feb 2025.